Generic Name: Denosumab (60mcg)
DENOCLAST 60MG INJECTION is used for managing and preventing bone complications, especially in cancer patients with bone metastases or hypercalcemia.
Contains 60 milligrams of denosumab, a monoclonal antibody that inhibits bone resorption.
Denosumab works by slowing down the breakdown of bone, reducing the risk of fractures and other skeletal problems.
DENOCLAST 60MG INJECTION helps improve bone health and reduce complications associated with bone disorders, contributing to a better quality of life for patients.

• Customer-Centric Solutions: Parshva Agency focuses on delivering tailored private labeling services on a Peer-to-Peer (P2P) basis to meet the unique needs of each client.
• Regulatory Support: The agency is backed by experienced regulatory experts who ensure full compliance with all industry standards, providing peace of mind to clients.
• State-of-the-Art Manufacturing: Partnered with advanced manufacturing facilities that meet WHO-GMP certifications, Parshva Agency emphasizes the importance of modern production techniques.
• Quality and Efficacy: With WHO-GMP certification, the agency guarantees that its products maintain the highest standards of quality and efficacy.
• Reliability: Parshva Agency is committed to providing safe, reliable, and compliant products that meet stringent regulatory guidelines, fostering trust among clients and stakeholders.